Aug 26, 2025
As of August 1, 2025, Ozempic litigation has reached 2,190 cases in MDL 3072, up from 2,000 in July. Medical evidence shows semaglutide users face 3.67 times higher risk of gastroparesis. Recent court rulings have rejected manufacturer preemption arguments, allowing fraud-based claims to proceed. May 2025 hearings addressed expert testimony...
10 Min Read